TherapeuticsMD

Bespreek hier de kleinere aandelen van de beurs in New York
mikkel
Forum newbie
Forum newbie
Berichten: 3
Lid geworden op: 28 Mei 2019 22:16
waarderingen: 2
Contact:

Re: TherapeuticsMD

Berichtdoor mikkel » 29 Mei 2019 16:25

3,12 nu, ls enige in de plus in mijn porto
Backerrr liked last!

Beleggen met zéér aantrekkelijke tarieven
(klik op broker en vraag vrijblijvend informatie aan)
MeXeM DEGIRO LYNX
Inbev à €6.000 €3,60 €4,28 €6,00
Extra's o.a. 3 maanden
gratis coaching
Geen kosten bij ETF
en turbo kernselectie
Gratis tips en geen
wisselkoersmarge
bekijk hier meer brokers


powered by Surfing Waves

vlaanderenwest
Forum gebruiker
Forum gebruiker
Berichten: 135
Lid geworden op: 26 Jun 2015 14:38
waarderingen: 48
Contact:

Re: TherapeuticsMD

Berichtdoor vlaanderenwest » 30 Mei 2019 11:38

Ik had niet verwacht dat ik ze zo snel al zou binnen halen, hoop dat het niet te vroeg was.
mijn gemiddelde is nu wel serieus gezakt sta nu op 4.19 $

Backerrr
Forum actieveling
Forum actieveling
Berichten: 320
Lid geworden op: 08 Aug 2018 18:39
waarderingen: 118
Contact:

Re: TherapeuticsMD

Berichtdoor Backerrr » 31 Mei 2019 16:10

Iemand op stocktwits:
$TXMD WOW! Imvexxy grew 20% last week. Approx 10,500-11,500 scripts for last week. Looking like 35-40k for May. Best growth this whole year. If this pace stays around 10-15% you are looking at 75k scripts a month in 4th qtr. That brings in 15 plus million just in imvexxy rev.

Benieuwd wat maandag 10 juni zal brengen.
Lama Daila liked last!

vlaanderenwest
Forum gebruiker
Forum gebruiker
Berichten: 135
Lid geworden op: 26 Jun 2015 14:38
waarderingen: 48
Contact:

Re: TherapeuticsMD

Berichtdoor vlaanderenwest » 04 Jun 2019 17:47

we gaan eindelijk eens terug omhoog

besportie
Forum veteraan
Forum veteraan
Berichten: 1097
Lid geworden op: 13 Feb 2012 18:07
waarderingen: 219
Contact:

Re: TherapeuticsMD

Berichtdoor besportie » 06 Jun 2019 19:53

Heb hier de indruk dat de 3$ - 3.20& wat een bodem vormt. Vandaag een eerste positie genomen aan 3.20$.
Volgende week 10 juni is er een presentatie gepland.
Turbo long Galapagos, Innate, Mithra / Aandelen: Pharnext, TherapeuticsMD, Macrogenics

Backerrr
Forum actieveling
Forum actieveling
Berichten: 320
Lid geworden op: 08 Aug 2018 18:39
waarderingen: 118
Contact:

Re: TherapeuticsMD

Berichtdoor Backerrr » 07 Jun 2019 13:27

Verdorie toch.... bedankt Txmd voor de goede start van mijn paar dagen vakantie :) :D

Gebruikersavatar
Naz-T
Forum actieveling
Forum actieveling
Berichten: 588
Lid geworden op: 06 Sep 2018 20:48
waarderingen: 214
Contact:

Re: TherapeuticsMD

Berichtdoor Naz-T » 07 Jun 2019 13:33

Backerrr schreef:Verdorie toch.... bedankt Txmd voor de goede start van mijn paar dagen vakantie :) :D


Zal leuk dagje worden ja. Verliezen van afgelopen weken wegwerken...
Backerrr liked last!

Gebruikersavatar
Lama Daila
Forum veteraan
Forum veteraan
Berichten: 1668
Lid geworden op: 20 Jul 2017 10:53
waarderingen: 2849
Contact:

Re: TherapeuticsMD

Berichtdoor Lama Daila » 07 Jun 2019 13:52

http://ir.therapeuticsmd.com/news-relea ... and-supply

TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
-Agreement leverages Theramex’s extensive women’s health capabilities and infrastructure to the benefit of menopausal women outside of U.S.-
-TherapeuticsMD to receive EUR 14 million as an upfront fee and is eligible to receive up to EUR 29.5 million in regulatory and sales milestone payments, as well as a royalty on net sales-
BOCA RATON, Fla.--(BUSINESS WIRE)--Jun. 7, 2019-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it has entered into an exclusive license and supply agreement with Theramex, a leading, global specialty pharmaceutical company dedicated to women’s health, to commercialize BIJUVA (estradiol and progesterone capsules) and IMVEXXY (estradiol vaginal inserts) outside of the United States. Theramex is a portfolio company of CVC Capital Partners.
Theramex will have exclusive commercialization rights for BIJUVA and IMVEXXY outside the U.S., excluding Canada and Israel, for which TherapeuticsMD has licensed BIJUVA and IMVEXXY to Knight Therapeutics. Theramex will be responsible for conducting all regulatory and commercial activities in connection with BIJUVA and IMVEXXY in the licensed territories.
Under the terms of the license and supply agreement, Theramex will pay TherapeuticsMD EUR 14 million in cash as an upfront fee. TherapeuticsMD is eligible to receive up to an additional EUR 29.5 million in cash milestone payments, comprised of (i) an aggregate of EUR 2 million in regulatory milestone payments based on regulatory approvals for each of BIJUVA and IMVEXXY in certain specified markets and (ii) an aggregate of EUR 27.5 million in sales milestone payments to be paid in escalating tranches based on first attaining certain aggregate annual net sales milestones in the licensed territories ranging from EUR 25 million to EUR 100 million. TherapeuticsMD is also entitled to receive royalty payments on net sales of BIJUVA and IMVEXXY in the licensed territories.
"We are very pleased to announce our partnership with Theramex to bring BIJUVA and IMVEXXY to women outside of the United States,” said Robert G. Finizio, CEO of TherapeuticsMD. “We believe this agreement provides our company with important non-dilutive upfront capital to help fund our product launches in the United States as well as an incremental royalty stream to support future growth.”
Anish Mehta, CEO of Theramex, said, “This partnership with TherapeuticsMD marks another exciting milestone in the execution of our women’s health growth strategy. By leveraging our best in class commercial capabilities and global footprint, we intend to rapidly commercialize these novel and innovative medicines for women around the world.”
“BIJUVA and IMVEXXY strengthens Theramex’s already exciting range of women’s health treatment options for doctors and their patients,” said Fred Hassan, Chairman of Theramex.
gerbil liked last!
https://twitter.com/lama_daila

Backerrr
Forum actieveling
Forum actieveling
Berichten: 320
Lid geworden op: 08 Aug 2018 18:39
waarderingen: 118
Contact:

Re: TherapeuticsMD

Berichtdoor Backerrr » 07 Jun 2019 19:10

gerbil liked last!

Backerrr
Forum actieveling
Forum actieveling
Berichten: 320
Lid geworden op: 08 Aug 2018 18:39
waarderingen: 118
Contact:

Re: TherapeuticsMD

Berichtdoor Backerrr » 10 Jun 2019 18:24

Imvexxy: 37700 voor de maand mei. Vagifem:37200


Word gratis lid op Beursig.com

Discussieer met duizenden beleggers en profiteer
van minder advertenties en abonneer op onderwerpen.

Registreer nu binnen enkele tellen